Tag: Sino Biopharmaceutical
Sidley steers Sino Biopharm, AstraZeneca licence agreement
Sidley Austin advises Sino Biopharmaceutical on an exclusive licence agreement between its subsidiary and AstraZeneca
Han Kun, Zhong Lun act on Sino Biopharm’s USD950m LaNova buy
Han Kun and Zhong Lun advised on Sino Biopharm’s USD950m acquisition of cancer drugmaker LaNova Medicines



















